Long-term or too frequent administration of the drug in young children can lead to inhibiting of the central nervous system, hypothermia, coma, and prolonged expansion of the pupil. Nafazolin can cause a sudden decrease in blood pressure and tachycardia.
There is no data regarding the acute overdose of drops injected locally into the conjunctival bag.
Hypersensitivity.
Sonnness, dry mouth, dizziness, nausea, headache, weakness, numbness of the mucous, decrease in reaction rate.
Drowsiness, dizziness, decreased reaction rate, headache, weakness, dry mouth, numbness of the mucous, nausea.
Increased excitability (especially in children).
Allergic diseases, allergodermatosis, peptic ulcer of the stomach and duodenum, insomnia, vomiting of pregnant women, Meniere syndrome, seasickness, radiation sickness, parkinsonism.
Allergic diseases, allergodermatosis, peptic ulcer of the stomach and duodenum, insomnia, vomiting of pregnant women, Meniere syndrome, seasickness, radiation sickness, parkinsonism.
Allergic reactions of the upper respiratory tract (pump, lacrimation, perm in the throat or nose), colds.
V / m - 1–5 ml 1% of the solution.
Inside - 0.025–0.05 g (children - 0.01–0.03 g) 1–3 times a day. The course is 10-15 days.
Outwardly. Adults and children over 2 years old Difenhidramina Fada® apply to affected areas of the skin (a strip of gel 3–5 cm long to the area of destruction the size of the palm) 3–4 times a day and distribute with light massaging movements.
V / m - 1–5 ml 1% of the solution. Inside, for adults - 25–50 mg 1–3 times a day.
Children - 10-30 mg 1-3 times a day. The course is 10-15 days.
Inside, adults - 2 tablets each. every 6 h, but no more than 12 tablets. per day.
Children from 6 to 12 years old - 1 table each. (no more than 6) per day. Children under 6 need a doctor’s consultation.